SVFC...here we come
As many as 4,500 clinical trials involving stem cells are underway in the United States to treat patients with heart disease, blindness, Parkinson’s, H.I.V., diabetes, blood cancers and spinal cord injuries, among other conditions.
Initial studies suggest that stem cell therapy can be delivered safely, said Dr. Ellen Feigal, senior vice president of research and development at the California Institute of Regenerative Medicine, the state stem cell agency, which has awarded more than $2 billion toward stem cell research since 2006 and is enrolling patients in 10 clinical trials this year.
